Zobrazeno 1 - 8
of 8
pro vyhledávání: '"D. F. Sergienko"'
Publikováno v:
Acta Biomedica Scientifica, Vol 7, Iss 4, Pp 101-108 (2022)
Background. Targeted therapy in patients with cystic fibrosis, which aims to restore the function of the cystic fibrosis transmembrane conductance regulator protein, is currently revolutionary in the treatment of the disease. The first drug available
Externí odkaz:
https://doaj.org/article/610044a4288f48b5a616144f5f4b27aa
Autor:
S. A. Krasovsky, E. L. Amelina, A. V. Chernyak, E. I. Kondratieva, J. V. Gorinova, O. G. Zonenko, D. F. Sergienko, A. R. Tatarsky
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 72-77 (2019)
A non-interventional prospective cohort study was conducted on adult patients with cystic fibrosis, who received mucolytic therapy with 7% NaCl solution combined with 0.1% hyaluronic acid (medical product Hyaneb) and 7% NaCl solution for 4 and 8 week
Externí odkaz:
https://doaj.org/article/b1391bb682a840169a28d588d7ea2e3b
Autor:
Ye. L. Amelina, I. K. Asherova, I. K. Volkov, Т. Ye. Gembitskaya, Ye. K. Ginter, N. А. Il’yenkova, N. I. Kapranov, I. P. Karimova, N. Yu. Kashirskaya, Ye. I. Kondrat’yeva, М. N. Kostyleva, S. А. Krasovsky, N. B. Merzlova, L. P. Nazarenko, L. S. Namazova-Baranova, А. F. Neretina, V. S. Nikonova, А. V. Orlov, S. S. Postnikov, Т. А. Protasova, S. Yu. Semykin, D. F. Sergienko, О. I. Simonova, I. D. Uspenskaya, М. Yu. Chernukha, L. А. Shabalova, I. А. Shaginyan, V. D. Sherman
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 6, Pp 89-95 (2014)
The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including gluco
Externí odkaz:
https://doaj.org/article/6524667aa0ed4fb08cf3767cd4dcf923
Publikováno v:
RUDN Journal of Medicine, Vol 22, Iss 2, Pp 183-190 (2018)
Syndrome of bronchial obstruction is a symptomatic complex arising on the background of constriction or occlusion of bronchial tubes of different caliber due to bronchospasm, edema and inflammation of the bronchial mucosa, hypersecretion of mucus or
Externí odkaz:
https://doaj.org/article/67648d47465541cf97304c03adf49f68
Publikováno v:
RUDN Journal of Medicine, Vol 22, Iss 1, Pp 102-105 (2018)
The article presents a clinical case of development cepacia syndrome in a patient with cystic fibrosis and the detailed 4-month therapy, which is repeatedly adjusted depending on the condition of the patient.
Externí odkaz:
https://doaj.org/article/df364e69f00049eb92d123720fb3dd38
Autor:
S. A. Krasovskiy, R. U. Kagazezhev, O. G. Zonenko, D. F. Sergienko, N. S. Butyugina, M. Y. Gushchin
Publikováno v:
Meditsinskiy sovet = Medical Council. :102-108
Introduction. Cystic fibrosis is a severe systemic multiorgan exocrinopathy, the severity of the condition in 95% cases is caused by the depth of respiratory organ damage. Symptom management drugs that were developed over more than 50 years allowed t
Publikováno v:
Rossijskij Vestnik Perinatologii i Pediatrii, Vol 66, Iss 1, Pp 66-72 (2021)
Objective: to study the clinical features of TORCH syndrome in newborns with congenital cytomegalovirus infection depending on body weight at birthCharacteristics of children and research methods. The study included 70 patients (43 premature, 27 full
Publikováno v:
RUDN Journal of Medicine, Vol 22, Iss 2, Pp 183-190 (2018)
Syndrome of bronchial obstruction is a symptomatic complex arising on the background of constriction or occlusion of bronchial tubes of different caliber due to bronchospasm, edema and inflammation of the bronchial mucosa, hypersecretion of mucus or